期刊文献+

冠脉通瘀汤对心肌缺血再灌注保护作用的研究 被引量:1

Protective Effects of Guanmaitongyu Decoction on Myocardial Ischemia reperfusion Injury in Rats
下载PDF
导出
摘要 目的观察冠脉通瘀汤对大鼠心肌缺血再灌注的保护作用及对冠心病患者心电图的影响。方法(1)建立大鼠心肌缺血再灌注模型,给药后观察心肌组织血清指标,了解冠脉通瘀汤的心肌保护效果;(2)冠心病患者61例随机分为对照组30例与观察组31例,均予西医常规治疗,观察组加服冠脉通瘀汤。结果(1)冠脉通瘀汤能降低血清中肌酸磷酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)及丙二醛(MDA)的含量,并能提高心肌组织中超氧化物歧化酶(SOD)的水平;(2)冠脉通瘀汤可使患者心电图的缺血性改变改善更佳。结论冠脉通瘀汤对大鼠心肌缺血再灌注有治疗性和预防性保护作用,并能有效改善患者心肌缺血的心电图。 Objective: To investigate the protective effects of Guanmaitongyu Decoction(GMTYD) on myocardial ischemia reperfusion injury in rats as well as the electrocardiogram of the coronary heart disease patients. Methods: After making up the myocardial ischemia reperfusion injury model, the rats were given different dosages of drug. The protective effects of GMTYD on cardiac muscles were observed by detecting the index in blood serum. Besides, 61 cornary heart disease patients were divided into the control group with 30 patients and the treatment group with 31 patients randomly. The control group was given the original western medicine, while the treatment group was added GMTYD on the basis of western medicine. Compared with the electcardiograms before and after 3 months treatment. Results: The experiment indicated that GMTYD decreased MB isoenzyme of creatine kinase (CK - MB), lactate dehydrogenase(LDH) and malondialdehyde(MDA) content in blood serum and also increased the content of superoxide dismutase(SOD) in cardiac musules. It improved the ischemia level on electcardiogram of patients. Conclusion: GMTYD has the therapeutic and preventive effect on myocaridal ischemia -reperfusion injury in rats and also availably improve the electcardiogram of the patients that suffer myocardial ischemia.
作者 陈潮 卢伟花
出处 《中国中医急症》 2008年第7期899-900,907,共3页 Journal of Emergency in Traditional Chinese Medicine
关键词 缺血再灌注 心肌保护 冠脉通瘀汤 Myocardial ischemia reperfusion injury Myocardial protection GMTYD
  • 相关文献

参考文献6

  • 1Bula LM. Myocardial ischemia and reperfusion injury[J] . Cardiovasc Pathol, 2005,14 : 170 - 174
  • 2赵广荣,向志军,元英进,郭治昕.中药现代化研究的生物技术[J].中草药,2004,35(5):481-484. 被引量:26
  • 3陈可冀.心脑血管疾病研究[M].上海:上海科技出版社,1998,316?..
  • 4中华人民共和国卫生部.中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002.243.
  • 5Beckman JS, Beckman TW, Chen, J, et al. Free in PMC apparenthydroxyl radical production by peroxy rite: implications for endothelial injury from nitric oxide and superroxide[J] . Proc Natl Acad Sci USA, 1990, 87(4): 1620
  • 6Yang XP, Liu YN, Peterson E, et al. Effect of neutral end peptidase24. 11 inhibition on myocardial ischemia/reperfusion injury: the role of kinins[J] . Cardio Vase Pharmoacol, 1997, 29 (2): 250 - 256

二级参考文献10

  • 1Jain K L.Proteomics:delivering new routes to drug discovery-Part 1 [J].Drug Discovery Today,2001,6:772-832.
  • 2Ong S E,Pandey A.An evaluation of the use of two-dimensional gel electrophoresis in proteomics [J].Biomol Eng,2001,18:195-205.
  • 3Cavalcoli J D.Genomic and proteomic databases,large-scale analysis and integration of data [J].Trands Cardiovas Med,2001,11:76-81.
  • 4Page M J,Amess B,Rohlff C,et al.Proteomics:a major new technology for the drug discovery process [J].Drug Discovery Today,1999,4:55-62.
  • 5YuanYJ LiuMY DongAJ.Key Technology for Production of Traditional Chinese Medicine (中药化化生产关键技术) [M].Beijing:Chemical Industry Press,2002..
  • 6HuZB LiuD.Status and role of biotechnology in TCM modernization in China [J].World Sci Technol-Modern Tradit Chin Med(世界科学技术-中药现代化),1999,1:23-35.
  • 7YuBY YanYQ.Analysis of relationship between methods of modern biology and modernization of traditional Chinese medicine [J].Wold Sci Technol-Modern Tradit Chin Med (世界科学技术-中药现代化),2001,3(4):45-49.
  • 8LiHJ LiP.Sustainable development of herbal plant resources and industry of traditional Chinese medicine [J].World Sci Technol-Modern Tradit Chin Med(世界科学技术-中药现代化),2001,3(2):55-57.
  • 9ChenHZ.Modernization of traditional Chinese medicine and herbal plant cultivation [J].World Sci Technol- Modern Tradit Chin Med(世界科学技术-中药现代化),1999,1:28-29.
  • 10ZhouH.Application and perspective of modern biotechnology in discrimination of TCM.首都医药,2001,8(3):5-5.

共引文献407

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部